First Foundation Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
+515
| New | +$229K | 0.01% | 312 |
|
|
2024
Q3 | – | Sell |
-347
| Closed | -$163K | – | 445 |
|
|
2024
Q2 | $163K | Sell |
347
-24
| -6% | -$11.2K | 0.01% | 337 |
|
|
2024
Q1 | $155K | Hold |
371
| – | – | 0.01% | 348 |
|
|
2023
Q4 | $151K | Sell |
371
-481
| -56% | -$196K | 0.01% | 358 |
|
|
2023
Q3 | $296K | Sell |
852
-109
| -11% | -$37.9K | 0.01% | 328 |
|
|
2023
Q2 | $338K | Buy |
961
+110
| +13% | +$38.7K | 0.01% | 296 |
|
|
2023
Q1 | $268K | Buy |
851
+9
| +1% | +$2.84K | 0.01% | 313 |
|
|
2022
Q4 | $243K | Buy |
+842
| New | +$243K | 0.01% | 338 |
|